News

UPM Biochemicals and Lehmann&Voss&Co. agree to exclusive Distribution Contract for UPM BioMotion™ Renewable Functional Fillers (RFF)

UPM Biochemicals Sales GmbH, Leuna, and Lehmann&Voss&Co. have reached an exclusive agreement regarding the distribution of renewable functional…

OMEGA-BUBBLES® C: Lehmann&Voss&Co. establishes new product range of brilliant white expanded glass granules

Lehmann&Voss&Co. expands its existing portfolio of lightweight fillers with highly pure white expanded glass granules called OMEGA-BUBBLES® C, which…

VITAFOODS reopened its doors again at one of the first European exhibitions

LEHVOSS Group presented its broad portfolio of nutraceutical ingredients, PHARMAGNESIA® nutrition minerals and pharma excipients at the world’s…

LEHVOSS Group strengthens its position in the European lubricants industry with the acquisition of GP2C

LEHVOSS Group welcomes the French company GP2C to combine their successful businesses. The Group sees a great opportunity to broaden their offering to…

LEHVOSS Group heads Innovate UK project – Overprinting with high-performance polymers (OverHIPP)

Additive Manufacturing (AM) is already opening up new possibilities in demanding applications. In order to further advance the relevant technologies,…

LEHVOSS Group strengthens its presence in the Nordic market thanks to a joint venture with Engredo ApS!

LEHVOSS group welcomes the Danish company Engredo to join forces and participate in the growth of the LEHVOSS nutritional business. The Group sees a…

Significantly increased TCT Asia 2021!

Another increase in the number of visitors on a larger exhibition area!

Restoridyn®: the power of polyphenols for Gut Health

According to research, Restoridyn® promotes a healthy balance of pro and anti-inflammatory biomarkers that may foster a healthy gut and healthy gut…

Busy Chinaplas 2021!

High interest on product news. Good visitor feedback!

AstaPure®: Benefits of Astaxanthin on Cardiovascular Health

According to data obtained from the World Health Organization, cardiovascular diseases accounted for 31% of all causes of death in 2016, and they are…
  • ....
  • 4
  • 5
  • 6
  • ....